Top Markets
Coin of the day
Eucrates Biomedical Acquisition Corp. Eucrates Biomedical Acquisition Corp.

Eucrates Biomedical Acquisition Corp.

EUCR
Pozycja w akcjach #26004
Eucrates Biomedical Acquisition Corp. currently lacks substantial business... Eucrates Biomedical Acquisition Corp. currently lacks substantial business operations. Its primary objective is to execute a corporate transaction such as a merger, stock swap, asset purchase, equity acquisition, restructuring, or another comparable strategic alliance involving one or more enterprises. Specifically, it aims to find and acquire a company operating within the life sciences or broader healthcare sectors across North America and Europe. Established in 2020, this entity has its headquarters situated in New York, New York.
Cena akcji
$10.04
Ostatnia synchronizacja: 2023-05-05
Kapitalizacja rynkowa
$44.29M
Zmiana (1 dzień)
0.00%
Zmiana (1 rok)
0.00%
Kraj
US
Handel Eucrates Biomedical Acquisition Corp. (EUCR)
Historia stopy dywidendy dla Eucrates Biomedical Acquisition Corp. (EUCR)
Stopa dywidendy (TTM) dla Eucrates Biomedical Acquisition Corp. (symbol akcji: EUCR) na dzień 2026 wynosi: 0
Średnia stopa dywidendy z ostatnich 5 lat: 0.00%
Historia stopy dywidendy dla Eucrates Biomedical Acquisition Corp. (EUCR) od 2026 do 2026
Stopa dywidendy na koniec każdego roku (TTM)
Rok Stopa dywidendy Zmień
Za mało danych dla podanych dat.
Stopy dywidendy (TTM) dla podobnych firm lub konkurencji